Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
Version v7-FR | Version v2-FR | |
---|---|---|
Language | French | French |
Date Updated | 2022-07-11 | 2022-06-03 |
Drug Identification Number | 02241795 | 02241795 |
Brand name | PROCYTOX TAB 25MG | PROCYTOX TAB 25MG |
Common or Proper name | Cyclophosphamide | Cyclophosphamide |
Company Name | BAXTER CORPORATION | BAXTER CORPORATION |
Ingredients | CYCLOPHOSPHAMIDE | CYCLOPHOSPHAMIDE |
Strength(s) | 25MG | 25MG |
Dosage form(s) | TABLET | TABLET |
Route of administration | ORAL ORAL | ORAL ORAL |
Packaging size | 200 Tablets/Bottle (Prod Code 2638B3933) | 200 Tablets/Bottle (Prod Code 2638B3933) |
ATC code | L01AA | L01AA |
ATC description | ALKYLATINGAGENTS | ALKYLATINGAGENTS |
Reason for shortage | Delay in shipping of the drug. | Delay in shipping of the drug. |
Anticipated start date | 2022-06-03 | 2022-06-03 |
Actual start date | 2022-06-03 | 2022-06-03 |
Estimated end date | 2022-07-08 | 2022-07-03 |
Actual end date | 2022-07-08 | |
Shortage status | Resolved | Anticipated shortage |
Tier 3 Status | No | No |
Company comments | PROCYTOX (Cyclophosphamide) 50mg oral tablets, baxter code 2638B1071 can be used as a substitute if aligned to clinical practice. | PROCYTOX (Cyclophosphamide) 50mg oral tablets, baxter code 2638B1071 can be used as a substitute if aligned to clinical practice. |
Health Canada comments |